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there is still no successful strategy to treat Huntington’s disease, an inherited autosomal disorder 
associated with the aggregation of mutated forms of the huntingtin protein containing polyglutamine 
tracts with more than 36 repeats. Recent experimental evidence is challenging the conventional view 
of the disease by revealing transcellular transfer of mutated huntingtin proteins which are able to 
seed oligomers involving wild type forms of the protein. Here we decipher the molecular mechanism 
of this unconventional heterogeneous oligomerization by performing discrete molecular dynamics 
simulations. We identify the most probable oligomer conformations and the molecular regions that 
can be targeted to destabilize them. Our computational findings are complemented experimentally 
by fluorescence-lifetime imaging microscopy/fluorescence resonance energy transfer (FLIM-FRET) of 
cells co-transfected with huntingtin proteins containing short and large polyglutamine tracts. Our work 
clarifies the structural features responsible for heterogeneous huntingtin aggregation with possible 
implications to contrast the prion-like spreading of Huntington’s disease.
Conformational diseases, such as Alzheimer’s, Parkinson’s and Huntington’s diseases, are part of an increasingly 
common class of neurological disorders characterized by the aggregation of aberrant conformations of proteins. 
In particular, Huntington’s disease (HD) has autosomal dominant inheritance and is caused by mutations leading 
to an abnormal expansion in the polyglutamine (polyQ) tract of the huntingtin (HTT) protein, leading to the 
formation of HTT inclusion bodies in the brain1,2. The severity of the illness may depends on the polyQ repeat 
length and the disease arises only in subjects where the polyQ region displays 36 repeats or more3–5. The molecu-
lar mechanism of Huntington’s disease has not been completely elucidated, but the general consensus is that the 
polyQ expansion in the HTT gene’s first exon is susceptible to atypical folding behaviors that somehow interfere 
with normal neuronal functions or survival6. Expressing only the first exon of the HTT gene is enough to observe 
HD pathogenesis in mice and toxicity in cells7.
Although Huntington’s disease is a cell autonomous genetic disorder, recent experimental work, both in vitro 
and in vivo, shows that mutant huntingtin proteins can be transmitted to neighboring cells8–11 with potential 
prion-like infection and propagation12,13. Remarkably, transcellular transmission of mutated huntingtin proteins 
leads to heterogeneous aggregation with wild type forms of the protein9,10. Considerable experimental4,14,15 and 
computational5,16,17 efforts have been devoted to elucidate the molecular mechanism underlying homogeneous 
aggregation of HTT in a polyQ dependent manner, while heterogeneous aggregation of HTT proteins with differ-
ent lengths of the polyQ tract is much less studied18,19, despite its fundamental relevance for a possible prion-like 
disease expansion.
Much of the knowledge on polyQ-dependent aggregation has been derived from model peptides with numer-
ous studies conducted on isolated polyQ monomers and oligomers4. The main problem is that the structural 
properties of monomeric polyQ are still unclear and inconsistent20. Experiments on single polyQ tracts of differ-
ent lengths, modified for solubility, suggest high conformational flexibility (a random coil, a collapsed structure, 
an α-helix, a β-sheet, or even a PP II helix) and a dependence of its structure on the local environment. It is 
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generally believed that polyQ aggregates adopt structures rich in β-sheet content with longer polyQ peptides 
aggregating faster.
The aggregation process in the cell is much more complex than for isolated polyQ tracts and depends also on 
the environment. To mimic the environment surrounding the polyQ regions in full-length proteins, some authors 
fused other soluble proteins to polyQ21. It is important to understand the relative contributions of the polyQ 
stretch and of the rest of the structure in modulating aggregation. Molecular dynamics simulations found a posi-
tive correlation between the length of the polyQ expansion and its probability to form a β-rich misfolded state16. 
On the basis of these simulations, it was concluded that the flanking sequences affect the formation of β-sheet 
structures in the polyQ region16. More recent simulations were able to reconstruct the free-energy landscape of 
the polyQ-dependent homogeneous HTT exon1 oligomerization5,17, investigating modifications of the structure 
by addition of specific residuals that enhance or inhibit oligomerization5. Molecular regions that inhibit hetero-
geneous HTT aggregation are however unknown, due to the lack of simulations for this case.
Here we investigate heterogeneous oligomerization of wild type HTT proteins with short polyQ tracts 
(Q < 36) and mutated ones with long polyQ tracts (Q > 36) numerically by discrete molecular dynamics simu-
lations and experimentally by fluorescence-lifetime imaging microscopy/fluorescence resonance energy transfer 
(FLIM-FRET) in cotransfected HeLa cells. Discrete molecular dynamics simulations allow to identify the the 
atomic mechanisms of oligomer formation and the main determinants of their stability, providing a list of possi-
ble molecular targets that could be exploited to inhibit aggregation.
Results
Discrete molecular dynamics simulations reveal structural features of huntingtin oligomers. 
To investigate heterogeneous oligomerization between mutant and non-mutant HTT proteins, we use discrete 
molecular dynamics (DMD), an event-driven simulation which employs a discrete potential energy that relies on 
the calculation of atomic collisions (for details see the Materials and Methods section)22–24. This technique has 
already been used to efficiently study the protein folding thermodynamics and protein oligomerization and allows 
for a good equilibration of the structures, as shown in Fig. S1 25. We focus our analysis on the HTT exon1, known 
to be responsible for the aggregation of mutant HTT6, and consider the interaction of two protein fragments 
with different length for the polyQ region. In particular, we consider combination of fragments of HTT-23Q, 
as a proxy for the wild type HTT, and HTT-74Q representing the mutant form of HTT. The Exon 1 amino acid 
sequence (reported in the SI) is composed by a first segment of 17 amino acids (HTT) followed by the glutamine 
repeat (polyQ) of length n = 23 or 74, a 11- (P11) and 10-proline (P10) stretch, interspersed with other regions of 
residues labeled as R17 and R12.
Figure 1 summarizes our results on the interaction between the simulated binary systems of Human HTT 
Exon 1 depending on the length of the polyglutamine chain (i.e. 23Q or 74Q). Panels from left to right refer 
respectively to systems HTT-Q23–HTT-Q23, HTT-74Q–HTT-74Q, and the combination of the wild-type and 
mutant protein, HTT-Q23–HTT-74Q. All plots refer to a low simulation temperature corresponding to physi-
ological conditions. Figure 1a–c reports the maps of the mean equilibrium distance between different residues. 
Secondary structures involving the two systems are observed in the off-diagonal squares, especially for the hetero-
geneous system, HTT-Q23–HTT-74Q. Studying these contact maps, we can infer information about regions that 
tend to be close and that could thus be involved in the oligomerization process. We define an aggregate precursors 
as a conformation displaying a β sheet that involves both proteins. To localize putative β sheet locations, we report 
in Fig. 1d–f the probability to find a β in the three systems considered.
For the HTT-Q23–HTT-Q23 binary system, the probability of β-sheet conformations in the polyQ region 
is lower in the first HTT-Q23 system than in the second one: 5% versus 20%, whereas the probability to form β 
structures in R12 and R17 domains is higher in both proteins. In the case of a pair of mutant HTT (HTT-74Q–
HTT-74Q), the probability of β-sheet conformations is larger than in the other systems, as expected. Continuous 
stretches of high beta probability (≥50%) are found in both polyQ, R12 and R17 regions, with high probability 
also in the N terminal of the first 74Q protein. Finally, Fig. 1f displays the per-residue β probability for the heter-
ogeneous system (HTT-Q23–HTT-74Q). The probability of β-sheet in the polyQ region of HTT-Q23 drastically 
increases with respect to the HTT-Q23–HTT-Q23 system, forming a stretch from residues 22 to 30. Furthermore, 
a high probability to find β-structure is found in the R12 and R17 domains of both proteins.
Cluster analysis identifies the most probable oligomer structures. In Fig. 1g–i, we show the most 
likely conformation resulting from the cluster analysis26 (see the Materials and Methods section). The color code 
for the different regions of the proteins is shown through a schematic box at the bottom of the panels. The two 
different proteins are colored in red or blue and reflect the color notation used for the axis label of the related 
plots. The putative oligomerization domain (a β shared among two proteins) is superimposed on the protein 
with a different color. Fig. S2a shows the number of structures for each identified cluster for the HTT-Q23–
HTT-Q23 binary system. The central structures of the first 9 clusters are reported. The most probable cluster con-
sists of more than 100 conformations. The most favorable structure, reported in Fig. 1g displays no cross β-sheet 
(Fig. S2), suggesting a lack of oligomerization for wild type HTT. We eventually find with a lower probability 
that the second cluster displays interaction between R12 of the first HTT and polyQ of the second one. The same 
interaction is then found again with even lower probability in the sixth cluster.
Figure S2b reports the number of structures for each identified cluster for the HTT-74Q–HTT-74Q binary 
system. The central structures of the first 7 clusters are reported. Differently from the HTT-Q23–HTT-Q23 case, 
here there is a single dominant cluster with more than 1000 structures whose conformation is reported in Fig. 1h. 
A β-cross interaction is found between the Htt terminal of the first HTT-74Q and polyQ domain of the second 
HTT-74Q. The clustering analysis indicates also the possibility of interaction between the polyQ of the two pro-
teins. Finally, Fig. S2c displays the number of structures for each identified cluster for the HTT-Q23–HTT-74Q 
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binary system. The central structures of the first 5 clusters are reported. Here, there is a single dominant cluster 
with more than 1000 structures whose conformation is reported in Fig. 1i where β-cross interactions are found 
between the R17 domain of HTT-Q23 and polyQ of HTT-74Q.
simulations reveal that a single mutant protein can aggregate two wild type forms. Our simu-
lations show that the binary system HTT-Q23–HTT-74Q can form aggregate precursors. We therefore investigate 
if this feature can be observed for a ternary system of Human HTT Exon 1, HTT-Q23–HTT-Q23–HTT-74Q. For 
the sake of clarity, we distinguish the two copies of the wild type protein with the notation HTT-23Qa and HTT-
23Qb. Figure 2a displays the mean distance as a function of the residue region. Again, closest cross-constructs 
between the possible pair combinations (HTT-23Qa–HTT-74Q, HTT-23Qa–HTT-23Qb, HTT-23Qb–HTT-
74Q) can be observed in the off-diagonal squares. Figure 2b reports the probability of β-sheets. For the HTT-74Q 
this probability is highest in the polyQ region and its values are larger here than in the HTT-23Q–HTT-74Q and 
HTT-74Q–HTT-74Q binary systems (compare with Fig. 1). Furthermore, both HTT-23Qa and HTT-23Qb pro-
teins show higher β probability in the R12 and R17 regions and in the last part of the polyQ tract (around residue 
38 and especially 270). The most favorable β-cross interactions in the ternary oligomer occur between HTT-23Qa 
and HTT-74Q, and in particular region R12 in HTT-23Qa with the polyQ of HTT-74Q (conformation shown in 
Fig. 2c), and among the three proteins (Fig. S3). The Htt-N terminal of HTT-23Qa aggregates with R12 of HTT-
23Qb, and the Htt-N terminal of HTT-23Qb aggregates with the polyQ of the 74Q protein.
Estimates of aggregate stability identifies possible targets. To decipher the structural mechanisms 
for HTT oligomerization and to identify the hot spots in HTT proteins which trigger the aggregation process, 
we calculate the destabilization effect of point mutations, evaluating the change in free energy (ΔΔG) upon 
g) h) i)
Figure 1. Discrete molecular dynamics simulations display β structure formation indicative heterogeneous 
HTT dimer formation. From left to right the three panels refer to HTT-23Q–HTT-23Q, HTT-74Q–HTT-74Q 
and HTT-23Q–HTT-74Q systems. (a–c) The mean smallest distance maps between different residue regions. 
(d–f) The β probability per-residue for the different residue regions. Error bars on each point are smaller than 
Δ = .p 0 015. (g–i) Most favorable conformational structures obtained via cluster analysis. The regions of 
interaction between two respective proteins having β-cross conformations, the precursors of aggregation, are 
colored differently from the rest of the protein.
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mutation27, as discussed in the Materials and Methods section. We consider the representative structures of oli-
gomers obtained from the cluster analysis and look for the most important interactions between monomeric 
subunits. Calculations are performed for all the cases considered in this work.
For the heterogeneous case, visual inspection of HTT-23Q–HTT-74Q oligomer structure (see Fig. 1i) shows 
β-cross interactions between anti-parallel β-sheets formed by a poly-Q region (in HTT-23Q) and the P11 region 
(in HTT-74Q). A smaller β-cross interaction is observed also between R17 of HTT-23Q and polyQ of HTT-74Q. 
It is worth noting here that the amount of aggregation is higher in HTT-23Q–HTT-74Q system in comparison to 
the oligomerization in the HTT-23Q–HTT-23Q system where it is absent (see Fig. 1g). Hence, we analyze impor-
tant H-bond interactions between 23Q and 74Q subunits and perform ΔΔG calculations on the most relevant 
cases. Residue Q175 located in the polyQ region of HTT-74Q has strong H-bond interactions with R17 of HTT-
23Q, specifically with residues L64 and P65. Further, residues Q37 and Q38, located in the polyQ of HTT-23Q, 
have H-bond interactions with residues in the P11 region of HTT-74Q, P191 and P192 respectively. In addition 
Q38 displays H-bond interaction with L194 residue in R17 region of HTT-74Q.
As shown in Fig. 3, substitution of the W residue at all the selected positions mostly induces destabilization on 
the oligomer structure due to its bulky and aromatic side chain. Furthermore, calculations on Q37 (Fig. 3a) and 
Q38 (Fig. 3b), residues show a similar trend in stabilization/destabilization activity on the quaternary structure 
of the aggregate. In particular, the substitution of residues such as M, I and Y induces significant stability in the 
HTT-23Q–HTT-74Q aggregate, while the substitution of G at all chosen positions in the polyQ regions has a 
significant destabilization effect. Interestingly, mutation of Q37 to P37 shows a remarkable disruption effect on 
the assembly of HTT-23Q–HTT-74Q oligomer structures. Furthermore, Eris calculations on residue Q175 posi-
tioned in the polyQ of HTT-74Q display similar stabilization/destabilization effects with all amino acids, to Q37 
especially when substituting a P residue. The insertion of either G or W residue in place of P192 and L194 has del-
eterious effects on the quaternary structure of the HTT-23Q–HTT-74Q oligomer. Furthermore we observe that 
almost all mutations at residue position P191 and L64 have destabilized the structure of HTT-23Q–HTT-74Q, 
which suggests the significance of this two residues at the oligomer’s interface. Finally, we perform a similar analy-
sis for the HTT-74Q–HTT-74Q binary system and for the HTT-23Q–HTT-23Q–HTT-74Q ternary systems. The 
results are reported in Figs S4 and S5, respectively.
FLIM-FRET experiments indicate heterogeneous HTT aggregation in cells. To confirm that 
aggregation between mutant and wild type HTT proteins occurs in cells, we cotransfect HeLa cells with 
PRK-RFP-exon1 HTT with 20Q, as a proxy for wild type HTT, and with pEGFP-exon 1 HTT with 74Q, repre-
senting mutated HTT. In these conditions, HeLa cells express both wild type and aberrant proteins linked to two 
distinct fluorochromes, as shown in Fig. 4a,b. Since fluorescence colocalization does not guarantee that the two 
Figure 2. Discrete molecular dynamics simulations indicate that a single HTT-74Q protein can trigger 
oligomerization of two HTT-23Q proteins. (a) Mean smallest distance map between different residue regions 
for the system HTT-23Q–HTT-23Q–HTT-74Q. (b) Per-residue β probability for the different residue regions. 
Error bars on each point are smaller than Δ = .p 0 015. (c) Most favorable conformational structure obtained via 
cluster analysis. The regions of interaction between the respective proteins having β-cross conformations, the 
precursors of aggregation, are colored differently from the rest of the protein.
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proteins are in close proximity, we perform a FLIM-FRET analysis28. With this technique it is possible to estimate 
the fluorescence decay time of a donor molecule following a pulse of excitation time. When the donor and the 
acceptor are closer than 10 nm, the signal results in a decrease of the fluorescence lifetime of the donor molecule.
Figure 4c shows a clear decrease in the average lifetime in the regions where the two types of HTT proteins 
are co-localized (Fig. 4c) and a corresponding change in the lifetime distribution (Fig. 4d) and average lifetime 
(Fig. 4e). This result implies that two HTT proteins with polyQ of different lengths are found in very close prox-
imity and are thus likely to form an oligomer or an aggregate.
Discussion
Huntington’s disease is caused by an autosomal dominant mutation in the HTT gene leading to progressive neu-
rodegeneration associated with protein aggregation in the nuclei of neuronal cells. Aggregation happens usually 
when the HTT protein contains an expanded polyQ region with more than 36 repeats. While the precise role of 
these aggregates is still debated in the scientific literature, their accumulation is a prerequisite for neurotoxicity, 
as recently reviewed29. Hence, detailed understanding on molecular mechanisms underlying HTT aggregation is 
necessary to identify possible peptides that may interfere with the process5. Most of the accumulated knowledge 
in this area refers to homogeneous aggregation of HTT with extended polyQ regions, while much less is known 
about heterogeneous aggregation of mutant and wild type forms of the protein. The possibility of heterogeneous 
aggregation was revealed more than a decade ago by experiments in vitro18 but received a renewed attention only 
in recent years thanks to recent experiments showing transcellular propagation of mutated HTT proteins in the 
Drosophila9,10 and mouse brain8.
In this paper, we explored molecular mechanism behind the unconventional HTT aggregation through 
MD simulations and compared heterogeneous and homogeneous oligomerization of HTT proteins. Our 
Figure 3. Selected amino acid induced mutations can destabilize the HTT-23Q–HTT-74Q oligomers. 
Destabilizing (stabilizing) mutations are marked with red (blue) dots. Residue Q175 located in the polyQ region 
of HTT74Q has strong H-bond interactions with R17 of HTT23Q, specifically with residues L64 and P65. 
Further, residues Q37 and Q38, located in the polyQ of HTT-23Q, have H-bond interactions with residues in 
the P11 region of HTT-74Q, P191 and P192 respectively. In addition Q38 displays H-bond interaction with 
L194 residue in R17 region of HTT-74Q (aggregate shown in Fig. 1i). Blue labels refer to mutation of the amino 
acids belonging to HTT-23Q while red ones to HTT-74Q. The green axis label correspond to residues located in 
polyQ region of HTT-23Q, while the magenta labels to R12 region of the mutant HTT-74Q (oligomer shown in 
Fig. 1i). Error bars are ±standard deviation.
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computational analyses complemented by experimental studies using FLIM-FRET have efficiently unraveled the 
mechanism of heterogeneous oligomerization. We deciphered how mutated HTT proteins could catalyze the 
aggregation process by generating strong HTT oligomers, comprising wild-type HTT proteins as well. This cat-
alytic activity of HTT mutants was efficiently captured by our in silico studies where the interaction of two HTT 
wild-type proteins with a single HTT mutants leads to the formation of oligomers.
To corroborate our numerical results experimentally, we performed the FLIM-FRET analysis on cells 
co-transfected with wild type and mutant HTT. Previous experimental evidence of heterogeneous HTT aggre-
gation and oligomerization was based on polymerization assays in vitro18 and fluorescence co-localization in cell 
lines18 and in animal models9. The FLIM-FRET technique allows to obtain a more convincing proof of intracellu-
lar aggregation since it is able to detect close proximity with greater sensitivity and precision than co-localization 
assays.
Having identified the structural mechanisms for HTT oligomerization, we identified hot spot residues that 
trigger the aggregation process through ΔΔG calculations27. Using this strategy, we were able to identify molec-
ular hot spots which could become possible targets to induce disaggregation and contrast the disease. According 
to our analysis the residues contributing to the heterogeneous oligomerization typically differ from those deter-
mining conventional oligomerization. This issue is important for the definition of molecular targets to inhibit 
aggregation, particularly in view of a possible prion-like propagation of Huntington’s disease12,13 that is emerging 
as a common feature in many neurodegenerative disorders, including Alzheimner’s and Parkinson’s diseases30.
Materials and Methods
simulations protocol. We use Discrete Molecular Dynamics (DMD) where the all-atom protein model 
interacts through the implicit solvent force-field Medusa which includes the van der Waals interaction, hydrogen 
bonds, electrostatic, dihedral and angular interactions and those due to the effective solvent. We perform replica 
exchange simulations to efficiently sample the energy landscape of the proteins31. For each simulated system, we 
Figure 4. FLIM-FRET analysis shows heterogeneous aggregation of mutant and wild type HTT. Exemple of 
EGFP-HTT-74Q (a) and RFP-HTT-20Q (b) signal in HeLa cells. (c) Average EGFP lifetime obtained fitting 
single-pixel distribution with four exponents. Decay time in pixel with less than 150 counts was set to zero. (d) 
The decay signal distributions from two regions (30 × 30 pixels) show different exponential tails, in agreement 
with average lifetime estimates. (e) Average lifetimes calculated from lifetime distribution over regions of 
30 × 30 pixels in 11 cells positive to EGFP-HTT-74Q and 14 cells positive to both EGFP-HTT-74Q and RFP-
HTT-20Q transfection.
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carry out simulations using 20 replicas of the system with temperature T in the range of 0.5–0.72 simulation units 
(this range has been previously investigated in16). We started each simulation from completely stretched confor-
mations, discarding the first part of the trajectories, that were not equilibrated due to the initial high energy. For 
the analysis, we only considered equilibrated trajectories (see Fig. S1). At a regular time interval of 1000 time units 
(approximately 50 ps), we exchange the temperatures of two replicas, also in line with previous work16. The dura-
tion of the simulation of each replica is about 4 × 106 time units (200 ns). For the analysis, we only consider 
equilibrated trajectories. A cubic box with periodic boundary condition has been employed for each simulated 
system. The analysis is performed using the GROMACS utility32; the secondary structures are computed using 
STRIDE33 and visualized with VMD34. Error bars on the estimated β-structure probabilities are obtained assum-
ing binomial statistics in the normal approximation yielding Δ = −p z p p N( (1 )/ )1/2, where p is the estimated 
probability, z = 1.96 for a 95% confidence level and N is the number of sampled configurations. In our simula-
tions, N = 4000 so that the upper bound on the error bar is Δ = .p 0 015max .
Aggregation maps: average beta structures between two proteins. To perform β-cross interac-
tion analysis we consider pairwise systems, searching for beta structures and in the second one. If their distance 
is less than 0.4 nm we measure the number of contacts between any pair of atoms from the respective group. We 
then average over the number of trajectory frames.
Cluster analysis: most probable structures. To determine the most probable structure of the target sys-
tem, we perform cluster analysis using the single linkage method26 using the single linkage method implemented 
in GROMACS32. We add a structure to a cluster when its distance to any element of the cluster is less than a cutoff, 
chosen to be 4 Å.
estimation of aggregate stability. Important interactions between different binding partners are found 
using the Eris molecular design suite27. Briefly, Eris substitutes all possible amino acids at chosen position sequen-
tially and re-packs the side chains of the residues surrounding the mutated site each time using a Monte Carlo 
simulated annealing procedure. Utilizing Medusa force field, Eris calculates the change of protein stability 
induced by the mutations with respect to the wild type protein in terms of ΔΔ = Δ − ΔG G Gmutant WT. Thus, 
positive and negative ΔΔG values signify destabilizing and stabilizing mutations respectively. It is worth to men-
tion here that the substitutions involving proline residues have resulted in heuristic values due to its cyclic struc-
ture and conformational rigidity. Hence, proline substitutions are omitted from most of the systems in the present 
study. Calculations are averaged over 250 iterations.
Cell culture and transfection. HeLa cells were maintained in DMEM (Euroclone, cod. ECM0060L) 
medium with 10% fetal bovine serum (Euroclone, ECS0180L), 100 U/ml penicillin, 100 mg/ml streptomycin 
sulphate (Euroclone, cod. ECB3001D) and 2 mM L-Glutamine (Euroclone, cod. ECB3000D-20) at 37 °C in an 
atmosphere of 5% CO2 and 95% humidity. Cells seeded at an 70% confluent onto 6-well plates were transiently 
transfected with PRK-RFP-exon1 HTT with 20Q (kindly provided from S. H. Li Laboratory, Emory University)35 
or pEGFP-exon 1 HTT with 74Q (Addgene, 40262) or cotrasfected with PRK-RFP-exon1 HTT with 20Q and 
pEGFP-exon 1 HTT with 74Q plasmids using Xfect transfection reagent (Clontech, cod 631317). After 48 h from 
transfection cells were used for live FLIM-FRET analysis.
Imaging and FLIM-FRET analysis. The FLIM-FRET technique allows to estimate the fluorescence decay 
time of a donor molecule following a pulse of excitation light28. Spectrally distinct fluorophores were chosen 
in such a way that the emission spectrum of the donor molecule (EGFP) overlaps the excitation spectrum of 
the acceptor molecule (RFP). When closer less than approximately 10 nm, the excited donor can transfer its 
energy to the acceptor, resulting in a decrease of the fluorescence lifetime of the donor molecule. Images were 
acquired with Leica TCS SP8 microscope and PicoQuant modules for Time-Correlated Single Photon Counting 
(TCSPC) in time-tagged time-resolved (TTTR) mode using 60x objective. The EGFP donor fluorophore was 
excited at 491 nm at a laser pulse frequency of 19.5 MHz. Average lifetime was calculated using FlimFit (v.5.1.1)36, 
Fiji-ImageJ (v.1.52e)37,38 PTUreader plugin (v.0.06). Biexponential function was used to fit pure EGFP lifetime, 
while for EGFP-RFP interacting fluorophores four exponential were used. Lifetimes were calculated on each pixel 
using a count threshold of 150. The instrument response function function was estimated directly from acquired 
images. Statistical analysis of the average lifetime was performed using 11 cells positive to EGFP-HTT-74Q and 14 
cells positive to both EGFP-HTT-74Q and RFP-HTT-20Q transfection, obtained from two independent experi-
ments. Statistical significance was established using the unpaired t-test.
Data Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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